Immunic Inc (NASDAQ: IMUX) kicked off on Tuesday, up 4.11% from the previous trading day, before settling in for the closing price of $0.73. Over the past 52 weeks, IMUX has traded in a range of $0.56-$1.42.
Annual sales at Healthcare sector company grew by 26.01% over the past five years. While this was happening, its average annual earnings per share was recorded 36.50%. With a float of $116.53 million, this company’s outstanding shares have now reached $120.28 million.
Immunic Inc (IMUX) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Immunic Inc is 3.12%, while institutional ownership is 51.08%. The most recent insider transaction that took place on Jun 13 ’25, was worth 16,694. In this transaction Executive Chairman of this company bought 20,000 shares at a rate of $0.83, taking the stock ownership to the 36,032 shares. Before that another transaction happened on Jun 05 ’25, when Company’s President and COO bought 12,512 for $0.79, making the entire transaction worth $9,884. This insider now owns 12,512 shares in total.
Immunic Inc (IMUX) Latest Financial update
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -0.25 earnings per share (EPS), lower than consensus estimate (set at -0.24) by -0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.12 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 36.50% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 24.52% during the next five years compared to 26.01% growth over the previous five years of trading.
Immunic Inc (NASDAQ: IMUX) Trading Performance Indicators
Take a look at Immunic Inc’s (IMUX) current performance indicators. Last quarter, stock had a quick ratio of 1.31.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.87, a number that is poised to hit -0.09 in the next quarter and is forecasted to reach -0.32 in one year’s time.
Technical Analysis of Immunic Inc (IMUX)
Immunic Inc (NASDAQ: IMUX) saw its 5-day average volume 1.39 million, a positive change from its year-to-date volume of 1.29 million. As of the previous 9 days, the stock’s Stochastic %D was 70.96%.
During the past 100 days, Immunic Inc’s (IMUX) raw stochastic average was set at 17.65%, which indicates a significant decrease from 60.48% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0536 in the past 14 days, which was lower than the 0.0636 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.8296, while its 200-day Moving Average is $0.9263. Nevertheless, the first resistance level for the watch stands at $0.7817 in the near term. At $0.8035, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.8294. If the price goes on to break the first support level at $0.7340, it is likely to go to the next support level at $0.7081. The third support level lies at $0.6863 if the price breaches the second support level.
Immunic Inc (NASDAQ: IMUX) Key Stats
The company with the Market Capitalisation of 91.42 million has total of 120,285K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -100,510 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -25,580 K.
